Dr. Michael Scott Turner, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Fm 544, Suite 100, Lewisville, TX 75056 Phone: 972-394-4600 Fax: 972-394-4622 |
Dr. Joseph Richard Kilianski Iii, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1700 Fm 544 Ste 100, Lewisville, TX 75056 Phone: 972-394-4600 |
News Archive
Testifying before the United States Senate Special Committee on Aging, Dr. Leonard Wartofsky, president of The Endocrine Society strongly urged lawmakers to increase regulatory oversight of so-called "bioidentical hormones," which have been inaccurately promoted as a safer and more effective alternative to traditional hormone therapies for women.
Orexigen® Therapeutics, Inc. announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity. The NDA is based on a substantial body of evidence gathered through the Contrave Obesity Research (COR) clinical program, which included over 4,500 patients.
In the United Kingdom, health experts said that the country could face an exponentially growing death rate from COVID-19 within weeks unless urgent action is taken to control the spread of the virus. At present, the country has the highest official COVID-19 death toll in Europe and the fifth-largest across the globe.
Tennessee-based Community Health Systems, which runs 206 hospitals in 29 states, says no medical information was exposed, however.
› Verified 9 days ago